Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Aplasia of the lacrimal and salivary glands (ALSG) is a rare autosomal dominant disorder characterized by aplasia, atresia or hypoplasia of the lacrimal and salivary glands leading to varying features since infancy such as recurrent eye infections, irritable eyes, epiphora, xerostomia, dental caries, dental erosion and oral inflammation.
Features include: Carious teeth, Xerostomia, Absent lacrimal punctum, and Lacrimal gland hypoplasia and 1 more.
FGF10 encodes fibroblast growth factor 10 (208 aa). Plays an important role in the regulation of embryonic development, cell proliferation and cell differentiation. Required for normal branching morphogenesis. May play a role in wound healing Highest expression in Cervix Ectocervix (19.0 TPM) and Cervix Endocervix (15.9 TPM).
Aplasia of lacrimal and salivary glands is associated with mutations in the FGF10 gene on chromosome 5.
The FGF10 protein participates in HNF6- and FGF10-dependent synthesis of PDX1 protein, HNF1B- and FGF10-dependent synthesis of PTF1A protein, and FGFR2c mutants bind an expanded range of ligands pathways.
FGF10 is classified as a druggable target (Cell Surface, Clinically Actionable, Druggable Genome, and Growth Factor categories) with score 0.0.
Genetic testing for FGF10 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for aplasia of lacrimal and salivary glands has been reported in the published literature.
No clinical trials have been registered for aplasia of lacrimal and salivary glands.
4 publications have been identified in PubMed for aplasia of lacrimal and salivary glands. Research spans Case Report / Case Series (50%), Diagnostic / Biomarker (25%), and Basic Science / Preclinical (25%).
Ikeda S (2026). [PMID: 41828344](https://pubmed.ncbi.nlm.nih.gov/41828344/). *International journal of molecular sciences*. [Basic Science / Preclinical]
Li Y (2025). [PMID: 41533940](https://pubmed.ncbi.nlm.nih.gov/41533940/). *Investigative ophthalmology & visual science*. [Diagnostic / Biomarker]
Escalante-Reyes M (2025). [PMID: 41409311](https://pubmed.ncbi.nlm.nih.gov/41409311/). *Molecular syndromology*. [Case Report / Case Series]
Feng ZX (2024). [PMID: 38081329](https://pubmed.ncbi.nlm.nih.gov/38081329/). *Ophthalmology*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 11:36 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center